RGD-Binding Integrins in Prostate Cancer: Expression Patterns and Therapeutic Prospects against Bone Metastasis
Prostate cancer is the third leading cause of male cancer deaths in the developed world. The current lack of highly specific detection methods and efficient therapeutic agents for advanced disease have been identified as problems requiring further research. The integrins play a vital role in the cro...
Main Authors: | Helen M. Sheldrake, Steven D. Shnyder, Andrew Gordon, Mark Sutherland, Laurence H. Patterson |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2012-10-01
|
Series: | Cancers |
Subjects: | |
Online Access: | http://www.mdpi.com/2072-6694/4/4/1106 |
Similar Items
-
Click Chemistry for the Synthesis of RGD-Containing Integrin Ligands
by: Matteo Colombo, et al.
Published: (2010-01-01) -
Pharmacologic inhibition of RGD‐binding integrins ameliorates fibrosis and improves function following kidney injury
by: Jeannine Basta, et al.
Published: (2020-04-01) -
RGD-Binding Integrins Revisited: How Recently Discovered Functions and Novel Synthetic Ligands (Re-)Shape an Ever-Evolving Field
by: Beatrice S. Ludwig, et al.
Published: (2021-04-01) -
Investigating the Interaction of Cyclic RGD Peptidomimetics with αVβ6 Integrin by Biochemical and Molecular Docking Studies
by: Monica Civera, et al.
Published: (2017-09-01) -
The effect of antagonizing RGD-binding integrin activity in papillary thyroid cancer cell lines
by: Cheng W, et al.
Published: (2016-03-01)